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Non-edible parts of Solanum stramoniifolium Jacq.
– a new potent source of bioactive extracts rich in
phenolic compounds for functional foods
Blanka Svobodova,a,b Lillian Barros, *a,c Tomas Sopik, b Ricardo C. Calhelha,a
Sandrina Heleno, a Maria Jose Alves,d Simone Walcott,e Vlastimil Kubanb and
Isabel C. F. R. Ferreira*a
Extracts prepared from leaves, roots, and stems of Solanum stramoniifolium Jacq. (Solanaceae) in 80%
ethanol have been tested for their in vitro antioxidant, anti-inﬂammatory, antimicrobial, and cytotoxic
activities with an aim to ﬁnd new sources of substances for functional foods and food additives. The root
extract revealed the highest antioxidant activity in all assays exceeding the trolox capacity, and was the
only extract that inhibited nitric oxide production in mouse macrophage cells, showing also the capacity
to suppress the growth of all tested human tumor cell lines (MCF-7, NCI-H460, HeLa and HepG2). The
leaf extract showed the strongest antimicrobial activity inhibiting all tested clinical isolates. To the author’s
best knowledge it was the ﬁrst time that all individual parts of this plant were tested for biological activity
together with the phenolic compound characterization.
1. Introduction
In recent years, food industry is interested in the application
of naturally occurring phytochemical compounds with biologi-
cal activity to food products to enhance their nutraceutical
value, health benefits, safety and shelf-life.1 Moreover, custo-
mer demand for more natural and safer food additives and the
growing number of chronic diseases motivate scientists to
search for new substances that would meet such expectations.2
Plants from tropical regions, such as Trinidad and Tobago,
grow in a highly competitive environment and therefore
produce large amounts of secondary metabolites for their
defense. These edible and medicinal plants, usually rich in
polyphenols, are often a good source of new bioactive com-
pounds.3 Solanum stramoniifolium Jacq. (coco-chat) is a hairy
fruited pea-eggplant of the Solanaceae family with distribution
in Asia, South America, Mesoamerica, and the Caribbean
region. It is a perennial shrub, 1 to 2 meters high and about as
broad; its stems, branches as well as leaves are sparsely
prickly. Fruits are 1–2 cm in diameter, globose, hairy, orange
or red when ripe.4 The ripe fruits are consumed while leaves
and roots are used in traditional medicine to treat thrush,
cold, venereal diseases, inflammation, asthma, arthritis, liver
problems, malaria and cancer.5–8
In S. stramoniifolium plants originating from Thailand,
fruits have been excessively tested, however other plant parts
remain unexplored. The antioxidant activity (DPPH and ABTS
tests, respectively) of water and methanol extracts was
described as weak and explained by the low total phenolic
content in the fruits.9,10 Methanol and ethyl acetate extracts of
fruits inhibited Gram-negative bacteria Escherichia coli in the
disc diﬀusion test, however the same extracts showed no
activity against Salmonella typhimurium, Shigella sonnei,
Helicobacter pylori, Streptococcus pyogenase, Salmonella typhi,
Staphylococcus aureus, Streptococcus viridians, and Enterococci
sp.11 On the contrary, the water extract of seeds contained
small proteins (MW < 14.4 kDa) with significant antimicrobial
activity against both Gram-positive and Gram-negative bacteria
with Bacillus subtilis, Bacillus licheniformis and Pseudomonas
aeruginosa being the most sensitive in the disc diﬀusion test,
and with no inhibition of E. coli and Klebsiella pneumoniae.12
The bioactive compounds of this species are, nevertheless,
unexplored. The ethanolic extract of roots revealed the
presence of alkaloids, flavonoids, tannins, triterpenes and
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saponins in a Brazilian study.13 The only study on phytochem-
ical compounds of S. stramoniifolium from Trinidad and
Tobago described the isolation of solamargine, a solasodine
glycoalkaloid.14
According to the World Health Organization, chronic dis-
orders such as cancer, diabetes and hypertension are becom-
ing the major causes of mortality not only in Trinidad and
Tobago, but also worldwide.15 Therefore, it would be desirable
to search for new tropical plant sources rich in bioactive com-
pounds that can be applied either as nutraceuticals or in func-
tional foods to fight and prevent these diseases. The combi-
nation of the health benefits, lately required by consumers,
and the positive role in food safety and storage due to the
strong antimicrobial and antioxidant activity of this plant may
be of great interest to the modern food industry in develop-
ment of new products.
To the author’s best knowledge, this is the first detailed
study of individual parts, such as leaves, stems and roots of
S. stramoniifolium reporting their anti-inflammatory, anti-
microbial, antioxidant, and cytotoxic activities associated with
the phenolic compound profiles.
2. Materials and methods
2.1. Reagents and standards
Acetonitrile 99.9% of HPLC grade was from Fisher Scientific
(Lisbon, Portugal). The standards trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), β-carotene and ellipti-
cine were purchased from Sigma-Aldrich (St Louis, MO, USA),
as also acetic acid, phosphate buﬀered saline (PBS), sulfo-
rhodamine B (SRB), and lipopolysaccharide (LPS). Phenolic
compound standards were from Extrasynthèse (Genay, France).
DPPH (2,2-diphenyl-1-picrylhydrazyl) was obtained from Alfa
Aesar (Ward Hill, MA, USA). The Griess reagent system was
purchased from Promega Corporation (Madison, WI, USA).
The culture media Muller Hinton broth (MHB) and Tryptic Soy
Broth (TSB) were obtained from Biomerieux (Marcy l’Etoile,
France). The dye p-iodonitrotetrazolium chloride (INT) was
purchased from Sigma-Aldrich (Spruce Street; St Louis, MO)
and was used as a microbial growth indicator. All other chemi-
cals were of analytical purity and obtained from common sup-
pliers. Water was treated via the purification system Milli-Q
water (TGI Pure Water Systems, Greenville, SC, USA).
2.2. Plant material
Plant material was harvested during May 2015 in Santa Cruz
area (Trinidad), after consultation with local healers. Table 1
presents the botanical name, local names, plant parts investi-
gated and popular uses of the plant in natural medicine. The
samples were authenticated by Dr Walcott at the National
Herbarium, University of West Indies, St Augustine Campus,
Trinidad and voucher specimen TRIN 40646 was deposited
thereby.
2.3. Preparation of plant extracts
Leaves, stems and roots were air dried separately right after
harvesting and ground to a fine powder by using an electric
laboratory scale mill (Grindomix, Retsch, Germany). Each
sample (1.5 g) was extracted twice with 30 mL of ethanol/water
(80 : 20, v/v) for 1 hour at 150 rpm and room temperature.
Subsequently, the supernatant was filtered through Whatman
No. 4 filter paper. Ethanol was then evaporated under vacuum
at 40 °C (Büchi R-210; Flawil, Switzerland) and the water
residue was lyophilized (FreeZone 4.5 model 7750031,
Labconco, Kansas City, MO, USA). The resulting fine powder
(20 mesh) was mixed to yield homogenized crude extracts and
stored in the dark at room temperature until tested. The meth-
odology routinely used in our laboratory was modified accord-
ing to ethnopharmaceutical requirements on solvents.16
2.4. Phenolic compounds’ profile
A routine method used in our laboratory was followed.17 Dry
lyophilized extracts were re-dissolved in water/ethanol (80 : 20,
v/v) using a sonic bath, filtered through a 0.22 µm nylon filter
and subjected to HPLC analysis.
Chromatographic data were acquired using a Dionex
Ultimate 3000 UPLC (Thermo Scientific, San Jose, CA, USA).
This system consists of a diode array detector coupled to an
electrospray ionization mass detector (LC-DAD-ESI/MSn), a
quaternary pump, an auto-sampler (kept at 5 °C), a degasser
Table 1 Ethnomedicinal information on Solanum stramoniifolium Jacq
Family Synonyms Vernacular names Ethnomedicinal use
Solanaceae Solanum demerarense Dunal Trinidad: coco-chat; Brazil: jóa,
jurubeba
Root: toothache, venereal diseases, malaria,
fever, cancer6
Solanum hirsutum Herb. Peurari ex Dunal Colombia: e-to-pa-a, kobu-yá,
uvilla
Leaves: thrush, cold, sores6
Solanum maccai Dunal Guyana: bura bura Fruits: sores, irritations, ant bites6
Solanum platyphyllum Dunal Peru: shiwánkush, coconilla27 Whole plant: chest pain, asthma,5 liver
problems7
Solanum stramonifolium Jacq. India: ram begun, tide begal5
Solanum toxicarium Lam.
Solanum toxicarum Rich.
Solanum trichocarpum Miq.
Solanum undecimangulare Willd. ex Roem. &
Schult.27
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and an automated thermostated column section (kept at
35 °C). The Waters Spherisorb S3 ODS-2 C18 (3 μm, 4.6 ×
150 mm, Waters, Milford, MA, USA) column was used for chro-
matographic separations. The solvents used were (A) 0.1%
formic acid in water and (B) acetonitrile. The gradient elution
applied was: 15% B (0–5 min), 15% B to 20% B (5–10 min),
20–25% B (10–20 min), 25–35% B (20–30 min), 35–50% B
(30–40 min), the column was then re-equilibrated, using a flow
rate of 0.5 mL min−1. Data were collected simultaneously with
a DAD (280 and 370 nm) and in a mass spectrometer. Negative
mode was chosen for MS detection on a Linear Ion Trap LTQ
XL mass spectrometer (ThermoFinnigan, San Jose, CA, USA).
Sheath gas (nitrogen) was kept at 50 psi. Other parameter set-
tings: source temperature: 325 °C, spray voltage: 5 kV, capillary
voltage: −20 V, tube lens oﬀset: −66 V, collision energy: 35
arbitrary units. The full scan captured the mass between m/z
100 and 1500. The Xcalibur® data system (ThermoFinnigan,
San Jose, CA, USA) was used for data acquisition.
For identification of the phenolic compounds, retention
times, UV-VIS and mass spectra were compared with available
standards. Data from the literature were used to tentatively
identify the remaining compounds. Calibration curves of avail-
able phenolic standards were constructed based on the UV
signal to perform quantitative analysis. Identified phenolic
compounds with unavailable commercial standard were quan-
tified via calibration curves of the most similar standard avail-
able. The results were expressed as mg g−1 of dry extract.
2.5. Biological activity screening
Antibacterial activity. Clinical isolates from patients hospi-
talized in the Local Health Unit of Bragança and Hospital
Centre of Trás-os-Montes and Alto-Douro-Vila Real, Northeast
of Portugal were used in the assay. Four Gram-positive bacteria
(Enterococcus faecalis isolated from urine; Listeria monocyto-
genes isolated from cerebrospinal fluid; MSSA: methicillin-sen-
sitive Staphylococcus aureus isolated from wound exudate and
MRSA: methicillin-resistant Staphylococcus aureus, isolated from
expectoration), and six Gram-negative bacteria (Acinetobacter
baumannii and Pseudomonas aeruginosa isolated from expectora-
tion; Escherichia coli, Escherichia coli spectrum extended produ-
cer of β-lactamases (ESBL); Klebsiella pneumoniae, Klebsiella
pneumoniae ESBL, all isolated from urine) were used to screen
the antibacterial activity of the extracts. Microorganism identifi-
cation and susceptibility tests were performed on the MicroScan
panels (MicroScan®; Siemens Medical Solutions Diagnostics,
West Sacramento, CA, USA) using the microdilution method.
The interpretation criteria were based on Interpretive
Breakpoints as indicated in the Clinical and Laboratory
Standards Institute18 and in the European Committee on
Antimicrobial Susceptibility Testing.19
A microdilution method with rapid p-iodonitrotetrazolium
chloride (INT) colorimetric assay according to Kuete et al.20
with some modifications was performed. The extract was
diluted in appropriate media according to bacterial require-
ments and successive dilutions were carried out in the wells
(20 to 0.156 mg mL−1 of final concentration). Three negative
controls (MHB/TSB, the extract, and medium with antibiotic)
and a positive control (MHB and each inoculum) were
prepared. For the Gram-negative bacteria, negative control
antibiotics, such as amikacin (K. pneumoniae ESBL
and P. aeruginosa), tobramycin (A. baumannii), amoxicillin/
clavulanic acid (E. coli and K. pneumoniae) and gentamicin
(E. coli ESBL) were used. The concentration used was based on
the MIC obtained (Table 2). For the Gram-positive bacteria,
ampicillin (L. monocytogenes) and vancomycin (MSSA, MRSA
and E. faecalis) were used (Table 3).
Table 2 Resistance proﬁle of Gram-negative bacteria to diﬀerent antibiotics; MIC values (µg ml−1)
Antibiotics
A.
baumannii E. coli E. coli ESBL
K.
pneumoniae
K.
pneumoniae
ESBL
P.
aeruginosa
Ampicillin na >8 R na >8 R ≥32 R na
Amoxicillin/clavulanic acid na ≤8/4 S na ≤8/4 S ≥32 R na
Amikacin na na 16 I na ≤2 S ≤8 S
Cefuroxime na ≤4 S na >8 R ≥64 R na
Cefotaxime >32 R ≤1 S na >2 R ≥64 R na
Ceftazidime 16 I ≤1 S ≥64 R na 16 R >8 R
Norfloxacin na >8 R na >1 R na na
Levofloxacin na na na na ≥8 R >2 R
Ciprofloxacin >2 R >1 R 0.5 S >1 R ≥4 R >1 R
Nitrofurantoin na ≤32 S na >64 R 256 R na
Fosfomycin na ≤16 S na ≤32 S na na
Colistin na na ≤0.5 S na na ≤4 S
Gentamicin 4 R >4 R ≤1 S ≤2 S ≥16 R >4 R
Imipenem na na 0.5 S na na >8 R
Meropenem na na ≤0.25 S na ≤0.25 >8 R
Piperacillin/tazobactam na na ≤4 I ≤8 S ≥128 R >16 R
Trimethoprim/sulfamethoxazole na >4/76 R ≤20 S >4/76 R ≥320 R na
Tobramycin ≤2 S na ≥16 R na ≥16 R >4 R
S – susceptible; I – intermediate; R – resistant; classification according to the interpretative breakpoints suggested by Clinical and Laboratory
Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST); na – not applicable.
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MIC was defined as the lowest extract concentration that
prevented the color change (from yellow dye to dark pink),
caused by viable microorganisms, and exhibited the complete
inhibition of bacterial growth.
Antioxidant activity. Hydroethanolic extracts were re-
dissolved in ethanol/water (80 : 20, v/v) to the final concentration
of 20 mg mL−1 and further diluted to 0.156 mg mL−1 to be
subjected to the following assays. The antioxidant activity was
evaluated by DPPH radical-scavenging activity, reducing power,
inhibition of β-carotene bleaching in the presence of linoleic
acid radicals and inhibition of lipid peroxidation using TBARS
in brain homogenates.21 The extract concentrations providing
50% of antioxidant activity or 0.5 of absorbance (EC50) were
calculated from the graphs of antioxidant activity percentages
(DPPH, β-carotene bleaching and TBARS assays) or absorbance
at 690 nm (reducing power assay) against extract concen-
trations. Trolox was used as a positive control.
Anti-inflammatory activity. The method previously described
by Correa et al.22 was performed in a concentration range
400–125 μg mL−1. Dexamethasone (50 μM) was used as a posi-
tive control. The mouse macrophage-like cell line RAW 264.7
stimulated with LPS was used in the assay. Nitric oxide (NO)
production was studied with a Griess Reagent System kit.
Results were expressed as EC50 values (μg mL−1) equal to the
sample concentration providing a 50% inhibition of NO
production.
Cytotoxicity. Dry extracts (stock concentration 8 mg mL−1,
re-dissolved in water) were further diluted to diﬀerent concen-
trations to be subjected to in vitro antitumor activity and
hepatotoxicity evaluation at final well concentrations
(400–1.5 μg mL−1). The cytotoxicity was determined using four
human tumour cell lines, HeLa (cervical carcinoma), HepG2
(hepatocellular carcinoma), MCF-7 (breast adenocarcinoma)
and NCI-H460 (non-small cell lung cancer), following a pro-
cedure already described by the authors.17 The cell growth inhi-
bition was measured using sulforhodamine B assay, where the
amount of pigmented cells is directly proportional to the total
protein mass and therefore to the number of bounded cells.
For hepatotoxicity evaluation, a freshly harvested porcine
liver, obtained from a local slaughter house, was used in order
to obtain the cell culture, designated as PLP2. The growth inhi-
bition was evaluated using the SRB assay, as previously
described.23 The results were expressed in GI50 values; sample
concentration that inhibited 50% of the net cell growth.
Ellipticine was used as a positive control.
2.6. Statistical analysis
Three repetitions (or two repetitions in case of antimicrobial
assay) of the samples were used and triplicates for each con-
centration reading were carried out in all the assays. Results
are expressed as mean values and standard deviations (SD).
The results were analyzed using one-way analysis of variance
(ANOVA) followed by Tukey’s HSD test with p = 0.05. When
necessary, a Student’s t-test was used to determine the signifi-
cant diﬀerence among two diﬀerent samples, with p = 0.05.
Both statistical treatments were carried out using the SPSS
v. 23.0 program.
3. Results and discussion
3.1 Phenolic compounds’ profile
Tables 4 and 5 present chromatographic data and tentative
determination of phenolic compounds in the hydroethanolic
extracts of leaves, stems, and roots of Solanum stramoniifolium
Jacq. In leaves, 6 phenolic acid derivatives and 14 flavonoids
(flavonol glycoside derivatives) were confirmed. Compounds 2
and 6 were positively identified as protocatechuic acid and
5-O-caﬀeoylquinic acid (chlorogenic acid) after comparing the
obtained LC-MS data with those of commercial standards.
Compound 5 was tentatively assigned as the corresponding cis
isomer of 5-O-caﬀeoylquinic acid based on its fragmentation
pattern and lower levels compared with peak 6. Furthermore,
cis hydroxycinnamoyl derivatives would be expected to elute
before the corresponding trans ones, as observed after
UV irradiation (366 nm, 24 h) of hydroxycinnamic acids in our
Table 3 Resistance proﬁle of Gram-positive bacteria to diﬀerent antibiotics; MIC values (µg ml−1)
Antibiotics MRSA MSSA E. faecalis L. monocytogenes
Penicillin >8 R ≤0.12 S na na
Ampicillin na na ≤4 S ≤0.2 S
Oxacillin >0.25 R ≤0.25 S na na
Clindamycin na >0.5 R na na
Erythromycin na >2 R na na
Ceftaroline ≤1 S na na na
Gentamicin na ≤1 S na na
Ciprofloxacin na >1 R na na
Levofloxacin na >2 R na na
Nitrofurantoin na na ≤64 S na
Linezolid ≤4 S na na na
Trimethoprim/sulfamethoxazole na ≤2/38 S na ≤2/38 S
Vancomycin ≤2 S ≤2 S ≤2 S na
MSSA – methicillin-sensitive Staphylococcus aureus; MRSA – methicillin-resistant Staphylococcus aureus; S – susceptible; I – intermediate; R –
resistant; classification according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute (CLSI) and European
Committee on Antimicrobial Susceptibility Testing (EUCAST); na – not applicable.
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laboratory.24 cis and trans isomers of 4-O-caﬀeoylquinic
acid (compounds 3 and 4) and trans 3-O-caﬀeoylquinic acid
(compound 1) were distinguished and identified by typical
fragmentation patterns as described by Cliﬀord et al.25,26 To
the best of our knowledge these compounds were described in
Solanum stramoniifolium Jacq. for the first time.
The flavonol derivatives detected in the leaf extract were
mainly glycosides of quercetin (λmax around 354 nm; MS
2 frag-
Table 4 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, and tentative identiﬁcation of
phenolic compounds in the hydroethanolic extract of Solanum stramoniifolium leaves
Compound Rt (min) λmax (nm)
Molecular ion
[M − H]− (m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1 dry extract)
1 5.1 328 353 191(100), 179(45),
172(4), 135(56)
3-O-Caﬀeoylquinic acid 6.49 ± 0.05
2 5.7 262, 292sh 153 119(100) Protocatechuic acid 0.37 ± 0.09
3 6.7 328 353 191(20), 179(19),
173(40), 135(27)
cis-4-O-Caﬀeoylquinic acid 1.73 ± 0.13
4 7.2 328 353 191(24), 179(28),
173(60), 134(48)
trans-4-O-Caﬀeoylquinic acid 2.59 ± 0.23
5 7.5 328 353 191(100), 179(12),
161(5), 135(20)
cis-5-O-Caﬀeoylquinic acid 2.21 ± 0.02
6 8.0 328 353 191(100), 179(52),
161(5), 135(34)
trans-5-O-Caﬀeoylquinic acid 3.66 ± 0.05
7 15.2 358 625 463(5), 301(100) Quercetin-O-dihexoside 0.11 ± 0.01
8 15.8 352 755 609(33), 301(100) Quercetin-O-deoxyhexosyl-O-rutinoside 2.49 ± 0.01
9 16.6 350 755 593(100), 285(38) Kaempferol-O-hexosyl-O-rutinoside 1.67 ± 0.01
10 17.2 354 609 301(100) Quercetin-3-O-rutinoside 0.707 ± 0.004
11 17.6 350 739 593(36), 285(95) Kaempferol-O-deoxyhexosyl-O-rutinoside 4.7 ± 0.1
12 17.9 346 755 593(100), 469(50),
285(72)
Kaempferol-O-hexosyl-O-deoxyhexosyl-hexoside 3.0 ± 0.1
13 18.3 356 769 623(40), 315(100) Isorhamnetin-O-deoxyhexoside-O-rutinoside 1.57 ± 0.01
14 19.6 350 593 285(100) Kaempferol-3-O-rutinoside 1.8 ± 0.1
15 20.6 354 623 315(100) Isorhamnetin-O-deoxyhexosyl-hexoside 1.31 ± 0.05
16 23.9 356 623 315(100) Isorhamnetin-3-O-rutinoside 0.366 ± 0.007
17 24.7 350 447 285(100) Kaempferol-3-O-glucoside 0.45 ± 0.03
18 25.4 354 477 315(100) Isorhamnetin-3-O-glucoside 1.5 ± 0.1
19 26.3 300sh, 334 771 609(51), 301(44) Quercetin-O-caﬀeoyl-rutinoside 0.78 ± 0.02
20 28.3 296sh, 332 755 593(9), 285(61) Kaempferol-O-caﬀeoyl-rutinoside 1.5 ± 0.1
Total phenolic acids 17.1 ± 0.5
Total flavonoids 22.0 ± 0.3
Total phenolic compounds 39.1 ± 0.7
Table 5 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, and tentative identiﬁcation of
phenolic compounds in the hydroethanolic extract of Solanum stramoniifolium roots and stems
Compound Rt (min) λmax (nm)
Molecular ion
[M − H]− (m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1 dry extract)
Student’s
t-testRoots Stems
5 7.3 328 353 191(100), 179(12),
161(5), 135(20)
cis-5-O-Caﬀeoylquinic acid 2.62 ± 0.22 1.26 ± 0.01 <0.001
6 7.9 328 353 191(100), 179(52),
161(5), 135(34)
trans-5-O-Caﬀeoylquinic acid 5.03 ± 0.14 3.42 ± 0.02 <0.001
21 17.4 236, 296,
320sh
472 350(40), 308(31) Bis(dihydrocaﬀeoyl)
spermidine isomer 1
1.86 ± 0.16 0.43 ± 0.01 <0.001
22 20.3 226, 294,
322sh
799 637(100), 515(6),
472(10), 350(3),
308(3)
Tris(dihydrocaﬀeoyl)
spermidine hexoside
0.63 ± 0.10 1.17 ± 0.01 <0.001
23 24.3 284 637 515(23), 472(47),
350(15), 308(8)
Tris(dihydrocaﬀeoyl)
spermidine
9.51 ± 0.08 1.06 ± 0.02 <0.001
24 29.4 226, 284,
316sh
472 350(32), 308(38) Bis(dihydrocaﬀeoyl)
spermidine isomer 2
0.78 ± 0.02 0.46 ± 0.05 <0.001
25 31.1 226, 292,
320sh
472 350(30), 308(48) Bis(dihydrocaﬀeoyl)
spermidine isomer 3
0.55 ± 0.09 1.08 ± 0.05 <0.001
Total phenolic compounds
and derivatives
20.98 ± 0.81 8.89 ± 0.01 <0.001
Food & Function Paper
This journal is © The Royal Society of Chemistry 2017 Food Funct., 2017, 8, 2013–2021 | 2017
Pu
bl
ish
ed
 o
n 
21
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 In
sti
tu
to
 P
ol
ite
cn
ic
o 
de
 B
ra
ga
nc
a 
on
 2
8/
01
/2
01
8 
21
:0
9:
32
. 
View Article Online
ment m/z 301), isorhamnetin (λmax around 356 nm; MS
2 frag-
ment m/z 317), and kaempferol (λmax around 348 nm, MS
2 frag-
ment m/z 285).
Quercetin-3-O-rutinoside (rutin; compound 10), kaemp-
ferol-3-O-rutinoside (nicotiflorin; compound 14), isorhamne-
tin-3-O-rutinoside (narcissin; compound 16), kaempferol-3-O-
glucoside (astragalin; compound 17) and isorhamnetin-3-O-
glucoside (compound 18) were positively identified upon com-
parison of their retention times, UV-Vis characteristics and
mass spectra with available commercial standards.
Compound 7 presented a pseudomolecular ion [M − H]− at
m/z 625, releasing a MS2 fragment at m/z 301 ([M − H − 162 −
162]−, loss of two hexosyl moieties), which led to its tentative
identification as quercetin-O-dihexoside. Compounds 8, 11,
and 13 provided the same fragmentation losses of deoxyhexose
(146 u) and deoxyhexosyl-hexose (308 u), indicating the
location of each residue on diﬀerent positions of the aglycons of
quercetin, kaempferol, and isorhamnetin ([M − H]− at m/z 755,
739, and 769, respectively). Similarly, MS2 fragments of peaks 9
and 12 revealed the alternative loss of hexosyl (m/z at 593; −162
u) and deoxyhexosyl-hexose (m/z at 285; −308 u) residues. The
positive identification of present rutinosides, including querce-
tin-3-O-rutinoside, in the samples may suggest a rutinoside
identity for the deoxyhexosyl-hexose residues in peaks 8, 9, 11
and 13. However, in the case of peak 12, the information about
the identity of the sugar moieties and location onto the aglycon
could not be confirmed, therefore the compound was tentatively
identified as kaempferol-O-hexosyl-O-deoxyhexosyl-hexoside.
Compound 15 ([M − H]− at m/z 623) presented the same pseudo-
molecular ion as compound 16, but showed an earlier retention
time. The observation of just a single MS2 fragment (m/z at 315;
−308 u), could indicate that the two sugar units were linked
together and the compound was tentatively assigned as isorham-
netin-O-deoxyhexosyl-hexoside.
Compounds 19 ([M − H]− at m/z 771) and 20 ([M − H]− at
m/z 755) could correspond to compounds including an acyla-
tion with a phenolic acid. The observation in their fragmenta-
tion of a product ion at m/z 609 and 593, respectively, from the
losses of caﬀeoyl residue (162 u), could also be coherent with
that identity, as well as the late elution, since the presence of
the hydroxycinnamoyl residue implies a decrease in polarity.
Therefore, these molecules were tentatively assigned to querce-
tin-O-caﬀeoyl-rutinoside and kaempferol-O-caﬀeoyl-rutinoside.
The root and stem extracts gave a similar phenolic profile,
obtaining diﬀerent quantities of seven identified compounds.
Compounds 5 and 6 were identified as 5-O-caﬀeoylquinic
isomers cis- and trans- as described above. The root extract
gave higher amounts of these substances than the stem
extract. Compounds 21, 24, and 25 ([M − H]− at m/z 472) were
thought to represent polyamine derivatives, namely three
isomers of N,N′-bis(dihydrocaﬀeoyl)spermidine as described
in the literature by Parr et al.27 Similarly, and taking into
account the findings reported by Gancel et al.28 compound 23
([M − H]− at m/z 637) lead to N,N′,N″-tris(dihydrocaﬀeoyl)sper-
midine and its hexoside, compound 22; [M − H]− at m/z 799,
which gives a MS2 fragment at m/z 637 [M − H − 162]−.
Nevertheless, a complete identification of the position of
dihydrocaﬀeoyl groups on the spermidine skeleton was not
possible. Compound 23 was the most abundant compound
present in both parts of this species.
Flavonoids were the most abundant group of phenolic com-
pounds identified in the present study. Nevertheless, polyamine
derivatives (spermidines) were dominant in the root and stem
extracts. To date, no record exists on spermidine derivatives in
S. stramoniifolium, however, their presence was frequently
described in other representatives of Solanum genus, such as
potato (S. tuberosum) or naranjilla fruit (S. quitoense).28,29
3.2. Biological activity
The increasing number of bacterial strains resistant to severe
available antibiotics remains a huge problem and is a driving
force for the search of new compounds with antimicrobial
activity.30 Furthermore, the food industry calls for natural anti-
microbial additives that would be eﬃcient and safe for human
consumption at the same time. Various natural peptides, poly-
saccharides, terpenes, and phenolic compounds have been
applied as food preservatives with no toxicity, such as thymol,
carvacrol, chitosan, and nisin.31
The crude extracts of leaves, stems, and roots of
S. stramoniifolium were tested for antimicrobial activity against
selected clinical isolates representing both Gram-positive and
Gram-negative bacteria: Acinetobacter baumannii, Klebsiella
pneumoniae, Pseudomonas aeruginosa and Staphylococcus
aureus, all known to exhibit multi-resistance to antibiotics and
labeled as the ESKAPE pathogens (Enterococcus faecium,
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter bau-
mannii, Pseudomonas aeruginosa, and Enterobacter species).32 It
is established that the Gram-negative bacteria possess stronger
resistance due to their protective outer membrane rich in lipo-
polysaccharides,33 which is missing in Gram-positive bacteria.
In Table 6, the results obtained from a broth microdilution
method with INT colorimetric evaluation are displayed. As can
Table 6 Antibacterial activity of Solanum stramoniifolium hydroethano-
lic extracts (MIC; mg mL−1)
Bacteria
MIC (mg mL−1)
Leaf Root Stem
Gram-positive strains
MRSA 5 10 5
MSSA 5 10 5
Enterococcus faecalis 5 10 10
Listeria monocytogenes 20 10 2.5
Gram-negative strains
Acinetobacter baumannii 10 10 >20
Escherichia coli 5 10 20
Escherichia coli ESBL 5 10 20
Klebsiella pneumoniae 5 10 20
Klebsiella pneumoniae ESBL 5 10 20
Pseudomonas aeruginosa 10 20 >20
ESBL = spectrum extended producer of β-lactamases. MIC = minimal
inhibition concentration. MRSA = methicillin-resistant Staphylococcus
aureus. MSSA = methicillin-sensitive Staphylococcus aureus.
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be seen, all three extracts exhibited antimicrobial activity to all
the assayed bacteria, and MICs ranged from 2.5 to 20
mg mL−1. In two cases, the MIC was above the maximal tested
concentration (stem extract against A. baumannii and
P. aeruginosa). In general, the Gram-positive bacteria were
more sensitive to the extracts than Gram-negative bacteria, as
expected. However, the root extract presented non-selective
inhibition providing the same MIC values for 9 of 10 bacterial
strains (10 mg mL−1). On the other hand, the stem extract was
significantly more active against Gram-positive bacteria.
Listeria monocytogenes was the most susceptible organism pro-
viding the lowest MICs in stem extract (2.5 mg mL−1).
P. aeruginosa was the least inhibited organism in the assay.
Overall, the leaf extract was the most eﬀective inhibitor with
MICs of 5 mg mL−1 obtained for 7 clinical isolates. Notably,
the bacteria with special characteristics, such as methicillin-
resistant MRSA or β-lactamase producing E. coli and
K. pneumoniae, did not present higher MICs than their more
sensitive analogues. The water extract of seeds from
S. stramoniifolium (Thailand) showed significant multispectral
inhibition (S. aureus, P. aeruginosa, Bacillus. subtilis, Bacillus
licheniformis, Xanthomonas sp., Salmonella typhi), however inhi-
bition of E. coli and K. pneumoniae were not observed in the
disc diﬀusion test.12
From the phenolic compounds identified in the plant
parts, nicotiflorin, rutin, and chlorogenic acid were previously
related with antimicrobial activity in the Solanum genus34 and
therefore can contribute to the inhibitory potential of this
species.
The results of antioxidant, anti-inflammatory and cytotoxic
activity are included in Table 7, due to their possible relation-
ship previously described in the literature.35,36 Polyphenol
extracts have been used in the food industry as they often exert
multiple biological activities in protection against spoilage
and oxidation via synergism of the compounds they contain.31
The antioxidant activity was evaluated using four in vitro
assays covering various mechanisms, such as hydrogen atom
transfer (HAT) and single electron transfer (SET), to fully
unfold the antioxidant capacity of the studied samples.37
As it can be observed in Table 7, all plant part extracts
showed significant antioxidant potential in the four assays
(DPPH; reducing power, β-carotene bleaching inhibition and
TBARS). The root extract stands out when compared to the
other plant parts. It was significantly more eﬀective than trolox
standard in all antioxidant assays, providing lower EC50 values
in each of the tested assays. Regarding DPPH scavenging
capacity assay, the plant parts were declining as follows: root >
leaf > stem with the corresponding EC50 values of 13 ± 1; 50 ±
2 and 74 ± 4 µg mL−1, respectively. In reducing power assay,
two extracts provided better results than the standard trolox
(EC50 = 41.7 ± 0.3 µg mL
−1), namely root and leaf (EC50 of
8.68 ± 0.03 and 23.7 ± 0.1 µg mL−1, respectively). The order of
activity in reducing power was: root > leaf > stem, as observed
in DPPH assay as well. Moreover, the same two extracts proved
to be better β-carotene bleaching inhibitors than trolox, as
only the stem extract gave a higher EC50 value than this stan-
dard (23.4 ± 0.4 versus 18 ± 1 µg mL−1). In the TBARS inhi-
bition test, only the root extract exceeded trolox capacity,
however the results were still quite promising (root > leaf >
stem; EC50 values corresponding to 15 ± 1; 33 ± 1 and 60 ±
1 µg mL−1, respectively). Previously, Wetwitayaklung and
Phaechamud10 observed low scavenging activity for the metha-
nol fruit extract of S. stramoniifolium in TEAC assay using the
ABTS+• radical (IC50 = 1133.08 µg compared to 10.14 µg for
trolox) and correlated it to the low presence of total phenolic
compounds (1.55 g gallic acid equivalents per 100 g extract).
Table 7 Biological activity of hydroethanolic extracts from diﬀerent parts of Solanum stramoniifolium Jacq
Leaf Root Stem Trolox
Antioxidant activity (EC50 values, µg mL
−1)
DPPH scavenging activity 50 ± 2b 13 ± 1d 74 ± 4a 41 ± 1c
β-Carotene bleaching inhibition 11.7 ± 0.1c 9.4 ± 0.5d 24.3 ± 0.4a 18 ± 1b
Reducing power 23.7 ± 0.1c 8.68 ± 0.03d 45 ± 0.3a 41.7 ± 0.3b
TBARS inhibition 33 ± 1b 15 ± 1d 60 ± 1a 23 ± 1c
Leaf Root Stem Dexamethasone
Anti-inflammatory activity (EC50 values, µg mL
−1)
Nitric oxide (NO) production >400 100 ± 6 >400 16 ± 1
Leaf Root Stem Ellipticine
Cytotoxicity to tumor cell lines (GI50 values, µg mL
−1)
HeLa (cervical carcinoma) 97 ± 4b 206 ± 15a >400 1.91 ± 0.06c
HepG2 (hepatocellular carcinoma) 85 ± 6a 40 ± 3b >400 1.1 ± 0.2c
MCF-7 (breast carcinoma) 206 ± 10b 52 ± 5c 242 ± 4a 0.91 ± 0.04d
NCI-H460 (non-small cell lung cancer) 155 ± 13a 113 ± 5b >400 1.0 ± 0.1c
Cytotoxicity to non-tumor cell lines (GI50 values, µg mL
−1)
PLP2 (porcine liver primary culture) >400 252 ± 10 >400 3.2 ± 0.7
Trolox, dexamethasone and ellipticine, respectively, were used as positive controls in the assays. All values are means ± SD (n = 9) and in each row
diﬀerent letters represent significant diﬀerences (p < 0.05).
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Lipid peroxidation products (e.g. malondialdehyde), as well
as free radicals, may damage important cell macromolecules,
such as DNA, proteins, and lipids and contribute to the devel-
opment of pathological processes, including aging, cancer,
atherosclerosis, coronary heart disease or neurodegenerative
problems.38 Despite the eﬀectiveness of endogenous anti-
oxidant systems, an exogenous source of antioxidants is
necessary in the case of excessive presence of oxidative species.
Therefore, prevention or limitation of oxidative stress might be
achieved by dietary antioxidants, such as phenolic-rich plant
extracts.
From the tested plant parts, only the root revealed activity
in the NO production (EC50 = 100 ± 6 µg mL
−1) as stated in
Table 7. Leaf and stem did not show any activity within the
maximal concentration tested (400 µg mL−1), which is surpris-
ing according to the traditional choice of leaves for external
inflammation. It can be suggested that other than NO pro-
duction-related mechanisms are involved and diﬀerent assays
shall be evaluated in future to study this activity.
More than 60% of agents used in cancer therapy are from
natural sources, especially tropical plants.39 The Solanum
genus is a good source for anticancer substances, such as sola-
nine or solamargine.40,41 The antitumor potential was evalu-
ated against four human tumor cell lines represented by
MCF-7 (breast carcinoma), NCI-H460 (non-small cell lung
cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular
carcinoma), and porcine liver primary culture PLP2 was
selected for cytotoxicity assessment against non-tumor cells.
Observing the results presented in Table 7, it can be concluded
that leaf and root are the most promising plant parts with anti-
tumor compounds as they inhibited all tumor cell lines used
in the study. The highest inhibition was found for HepG2,
yielding the lowest GI50 (40 ± 3 µg mL
−1 for root and 85 ± 6
µg mL−1 for leaf extract). The stem extract was eﬃcient only in
MCF-7 cell line inhibition (GI50 = 242 ± 4 µg mL
−1). The most
sensitive cell line was MCF-7, which was inhibited by all three
extracts in the following order root > leaf > stem. Interestingly,
the root extract provided lower GI50 for HepG2, MCF-7 and
NCI-H460 than leaf, but was less eﬀective against HeLa cell
line. Compared to ellipticine, the extracts revealed medium
activity. Nevertheless, ellipticine has a very strong inhibiting
power on all presented tumor cell lines, but also exhibits high
hepatotoxicity to non-tumor PLP2 cell line. In our case, only
root showed mild hepatotoxicity towards PLP2 (GI50 = 252 ±
10 µg mL−1), however it did not exceed active concentrations
against the tumor cell lines (40 ± 3 µg mL−1 in HepG2; 52 ±
5 µg mL−1 in MCF-7; 113 ± 5 µg mL−1 in NCI-H460; and 206 ±
15 µg mL−1 in HeLa).
Consequently, although the leaf and root extracts of
S. stramoniifolium could be useful in the development of new
anticancer products, the leaf is the most promising part, since
it did not present unspecific toxicity, as suggested by results
obtained with the PLP2 assay.
Due to the possible synergetic eﬀect of present compounds,
the plant crude extracts can often be a more powerful anti-
oxidant tool than individual substances. Moreover, the natural
matrices in the form of crude extracts possess usually very low
toxicity compared to individual chemicals and therefore are
currently experiencing a renaissance in both the phytopharma-
cological and food industry.31
4. Conclusions
This study highlights the potential of diﬀerent parts of
Solanum stramoniifolium Jacq. as a rich source of biologically
active compounds suitable for applications in the food indus-
try, for example in the development of novel functional foods
and nutraceutical formulations. Ethanol/water extracts from
leaves, stems, and roots demonstrated to have a strong biologi-
cal activity. The root extract gave the highest antioxidant poten-
tial exceeding trolox standard values. It also significantly
inhibited the growth of MCF-7 and HepG2 tumor cell lines.
The leaf extract showed the best results in the antimicrobial
assay inhibiting all the clinical bacterial isolates. Furthermore,
it did not possess any cytotoxicity, unlike the root extract, and
therefore might be a better candidate for the food industry.
The phenolic compounds in the extracts revealed the content
of compounds known for their biological activities, such as
caﬀeoylquinic acid derivatives, flavonoids and polyamines.
The presence of these compounds could be correlated with the
high biological activity shown by these extracts. Several com-
pounds were determined for the first time in this plant.
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